Share Name Share Symbol Market Type Share ISIN Share Description
Tyratech LSE:TYR London Ordinary Share USU890581080 COM SHS USD0.001 (DI / REGS)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 1.375p 1.25p 1.50p 1.375p 1.375p 1.375p 0 07:54:07
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 5.8 -1.8 -0.8 - 3.02

Tyratech Share Discussion Threads

Showing 2501 to 2525 of 2525 messages
Chat Pages: 101  100  99  98  97  96  95  94  93  92  91  90  Older
DateSubjectAuthorDiscuss
18/9/2017
06:12
Thegrumpster, Bruno Jactel joined Tyratech at the start of 2013 and decided it was high time they started to commercialise their IP. Just pointing that out like.
michaelsadvfn
17/9/2017
22:08
Prof Pitiful's alter-ego, one of many: Thegrumpster 15 Sep '17 - 21:20 - 1745 of 1745 1 0 (Filtered)
al h
15/9/2017
20:20
This has to be one of the most disappointing shares on AIM. They just do not seem to be able to make a go of anything. Used to be in this one years and years ago (2009? Pre TYRU) Actually made a bit of money when everything on AIM was going up. Got out because of some "dodgy" fund was involved (supposedly known for lending money, then pulling the plug)...they've gone. And there were too few trades....first person to sell crashed the share price. The University also seemed to be sliding out quietly....didn't seem to take part in additional fundraising, and they're not short of a bob or two. Lack of faith in their own technology, or the people running the company? The opportunities for their products are still out there. This for example, still relevant: Http://www.telegraph.co.uk/news/health/3342310/Dont-let-the-midges-bug-you.html ""According to Edinburgh University's Centre for Tropical Medicine, midges respond to the combination of chemicals - including lactic acid - present in the sweat of certain people, which they detect via their highly sensitive antennae. Research is focusing on the development of a repellent that can block receptor sites on midge antennae, but until such a product becomes available, those of us who are vulnerable must find other ways to manage the midges." "....It is estimated that midges cost the Scottish tourist industry up to £268 million a year in lost revenue, because many avoid visits during midge season. A forestry study carried out in the mid-1980s also suggested that 20 per cent of working days were lost because clouds of biting midges make timber felling and tree planting nigh impossible."" £268 million ten years ago. What are they losing now with the low pound, and the UK being a cheap destination for holidays? Midges? Http://www.freepatentsonline.com/8734869.html 2007 Tyratech 480p +20 Questor says Buy (Those were the days ....480 pee) Http://www.telegraph.co.uk/finance/markets/questor/2816630/Questor-A-shotgun-wedding-thats-worth-it.html "The arrival in the UK of the bluetongue virus this week, blown into the country by midges, served as a useful reminder than insect bites are not just a pain in the proverbial. They can devastate farmers' livelihoods and have brought animal movements across East Anglia to a complete halt. So it was particularly timely for Tyratech to publish its maiden results yesterday. The start-up (it listed on Aim this summer) is among a new breed of companies creating technology that should help create potent pesticides out of natural materials. It has located a number of receptors in parasites and insects that react to natural products. While this has been done before, the results have not always been totally effective. Tyratech claims to have taken the development a stage further, so that its plant-based products are now more powerful than chemical rivals. The potential benefits are enormous. Tyratech's natural products do less damage to the environment – increasingly important –as well as offering an alternative against insects that have developed a resistance to traditional products. What is more, as the receptors in insects are not found in mammals, the pesticides are literally fit to drink, and Tyratech is hoping to develop products that can combat intestinal parasites. As an investment case, the potential is clear but the risks are great. Tyratech's products are novel and it does not have a proven track record. The shares trade on a multiple of 30 times forecast earnings for 2009 (the first year it is expected to make a profit) falling to five times for 2011. It is not one for short-term investors or the risk-averse, but for others it's worth a punt." Seem to remember it was only about 30,000 shares sold, that brought it finally down to about 12p, in 2008, when things started looking ropey. Http://guardianrepellent.co.uk/ They've even got a product. Hopeless innit.
thegrumpster
02/8/2017
15:32
So did you have another splurge then, pre the two big dips.
willib2
04/7/2017
15:41
Well it can't be seen as bad news! How on earth is this company only valued at 5-6 million. At some point there will be a rerating so it will be interesting to see what happens tomorrow! Nobbygnome
nobbygnome
04/7/2017
14:43
An interesting RNS. The mini advantages set out in the announcement all seem fair enough, including a welcome boost to working capital. The potential longer term advantage is if -- big, big, if -- the products come to market and are successful, it should generate significant interest in the TYR technology across the piece. TYR has been here before with direct arrangements with big names (Kraft and Novartis Animal Health), without anything coming of it, but I hope that the repeated bites by these global players will eventually deliver value to TYR shareholders.
somerset lad
04/7/2017
10:06
Overhang gone and up she goes. No.3 on the risers list.
michaelsadvfn
01/6/2017
11:33
Someone joining me I see. Yes mudbath, I can live with it, I'm in for the long haul so it doesn't bother me. I'm wondering when we'll get this Vamousse valuation. It should cover the whole market cap and then some.
michaelsadvfn
01/6/2017
11:05
That had to be a good manoeuvre michael,even though it hits your portfolio valuation in the short term.
mudbath
01/6/2017
09:46
Nice 1.5m buy, unless the mm's are hiding the other half of a rollover. 475k left by my calcs, and they aren't wrong. Any further buying should see this marked back up. 0.94 offered. I just flipped 100k TYRU into 150k TYR.
michaelsadvfn
26/5/2017
10:10
2 more late 250k trades. 2.1m left.
michaelsadvfn
26/5/2017
10:06
All was explained by our CEO in this interview... https://www.youtube.com/watch?v=v1y4BL7pVkc Vamousse would never generate sufficient funds on it's own to support the rollout of Animal Health products which is where the serious money can be made. That's why. Vamousse is growing fast, OutSmart looks like another winner but the market is quite small($100m pa IIRC), Guardian got rave reviews and the PureScience products are being sold to the largest players in the U.S.A. The potential is there but the company is too small to go it alone so we will probably end up with multiple partners. At what cost I have no idea.
michaelsadvfn
26/5/2017
09:32
This company has never made a profit. It has a seemingly good product, Vamousse. Why doesn't it just concentrate on developing that. Get the group to a position where it makes a profit and grow the business from that? Or does it think it can keep coming to market for more money? This restructuring thing is just another chance for it to raise more money, looks like to me. Should I be tempted at these prices? Just been offered 1.65p for 10,000 shares on H-L.
voiceofreason
26/5/2017
08:43
Pity the buying has dried up. 2.6m to be cleared so I wouldn't expect any share price recovery until that has gone.
michaelsadvfn
25/5/2017
10:33
It is possible to sell TYR shares in size @ 0.9 this morning.
mudbath
24/5/2017
18:16
3.5m to clear then. Obviously an institution throwing away other people's money so it doesn't matter. I wonder whether these fund managers are so sloppy with their own money?
michaelsadvfn
24/5/2017
17:35
6,625,000 sold at 0.75p recorded late - mark no 20. Nice business for the MM.
pugugly
24/5/2017
15:16
4,662,895 TYR shares bought today so far, with no recorded sales.Restrictions on Transfer of the Company’s Securities Common shares in the capital of the Company are not registered under the US Securities Act of 1933 (Securities Act), as amended, the US Securities Exchange Act of 1934, as amended, or under any US state securities laws. As such, on issue common shares are “restricted securities” as defined in Rule 144 under the Securities Act and may not be resold in the United States absent registration under the Securities Act and any applicable securities laws of any U.S. State or pursuant to exemptions under the Securities Act and such laws. On issue common shares will be in certificated form with an appropriate form of restrictive legend and subject, in the case of shares subscribed and held by non-affiliates of the Company to a one year distribution compliance period under Regulation S under the Securities Act. During the distribution compliance period such common shares may only be traded through the delivery of physical certificates outside of the United States in offshore transactions to non-US Persons and otherwise in compliance with the Securities Act and any applicable securities laws of any state of the United States. Common shares subscribed and held by non-affiliates of the Company will be eligible to have the restrictive legend removed from their certificates representing such shares following the first anniversary of the issue of such shares and, on completion of an appropriate letter of transmittal available from the Company for migration of such shares to the Company’s unrestricted line of stock. A depositary interest facility is available that permits trades in shares in the Company’s unrestricted line of stock to be settled electronically through CREST rather than by delivery of physical certificates.
mudbath
24/5/2017
14:22
Mud ..thanks for that
ashtree2
24/5/2017
14:18
The shares were bought in two tranches,5,050,000 @ 1.75 pence on March 8th and 3,600,000 again @ 1.75 pence on March 16th(both after 5pm),with the TRI Notification being issued six days later. (At a cost of £151,000.) It might make sense if they were covering a client's large position with a time premium built in;with anything "long" due to hit the buffers for huge potential loss(but a result for Spreadex).
mudbath
24/5/2017
11:39
MUD So Spreadex bought TYR at 1.75 and are now offloading them at a massive loss,does that make any sense?
ashtree2
24/5/2017
11:35
I think it maybe has to do with the Spreadex holding of 8,650,000 TYR shares.If they have a client with a large position at around 1.75 pence,it might make sense to let the whole(or remaining)amount overhang the market whilst any contract moves towards expiry. If this is the case then we could see a sharp reversal in the TYR share price once the contract expires or even if it is rolled over. imo.
mudbath
24/5/2017
11:13
Anyone any idea who is selling down here,3 mil bought and no share price change,half wondering if this will fall further.
ashtree2
24/5/2017
10:30
Me too-producing 62% more Tyratech shares. Is this a free lunch ?
mudbath
24/5/2017
09:37
sold my tyru and bought tyr
ashtree2
Chat Pages: 101  100  99  98  97  96  95  94  93  92  91  90  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20171123 09:46:00